432 related articles for article (PubMed ID: 19564340)
21. Revisiting the mechanism of the autoactivation of the complement protease C1r in the C1 complex: structure of the active catalytic region of C1r.
Kardos J; Harmat V; Palló A; Barabás O; Szilágyi K; Gráf L; Náray-Szabó G; Goto Y; Závodszky P; Gál P
Mol Immunol; 2008 Mar; 45(6):1752-60. PubMed ID: 17996945
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein.
Sato T; Endo Y; Matsushita M; Fujita T
Int Immunol; 1994 Apr; 6(4):665-9. PubMed ID: 8018603
[TBL] [Abstract][Full Text] [Related]
23. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2.
Rossi V; Cseh S; Bally I; Thielens NM; Jensenius JC; Arlaud GJ
J Biol Chem; 2001 Nov; 276(44):40880-7. PubMed ID: 11527969
[TBL] [Abstract][Full Text] [Related]
24. Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation.
Dobó J; Schroeder V; Jenny L; Cervenak L; Závodszky P; Gál P
Mol Immunol; 2014 Oct; 61(2):69-78. PubMed ID: 24935208
[TBL] [Abstract][Full Text] [Related]
25. Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor.
Degn SE; Thiel S; Jensenius JC
Protein Expr Purif; 2013 Apr; 88(2):173-82. PubMed ID: 23314348
[TBL] [Abstract][Full Text] [Related]
26. Purification, crystallization and preliminary X-ray analysis of human mannose-binding lectin-associated serine protease-1 (MASP-1) catalytic region.
Dobó J; Harmat V; Sebestyén E; Beinrohr L; Závodszky P; Gál P
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Sep; 64(Pt 9):781-4. PubMed ID: 18765903
[TBL] [Abstract][Full Text] [Related]
27. The initiating proteases of the complement system: controlling the cleavage.
Duncan RC; Wijeyewickrema LC; Pike RN
Biochimie; 2008 Feb; 90(2):387-95. PubMed ID: 17850949
[TBL] [Abstract][Full Text] [Related]
28. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function.
Megyeri M; Makó V; Beinrohr L; Doleschall Z; Prohászka Z; Cervenak L; Závodszky P; Gál P
J Immunol; 2009 Sep; 183(5):3409-16. PubMed ID: 19667088
[TBL] [Abstract][Full Text] [Related]
29. The Structural Basis for Complement Inhibition by Gigastasin, a Protease Inhibitor from the Giant Amazon Leech.
Pang SS; Wijeyewickrema LC; Hor L; Tan S; Lameignere E; Conway EM; Blom AM; Mohlin FC; Liu X; Payne RJ; Whisstock JC; Pike RN
J Immunol; 2017 Dec; 199(11):3883-3891. PubMed ID: 29061764
[TBL] [Abstract][Full Text] [Related]
30. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
31. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.
Hisano S; Matsushita M; Fujita T; Takeshita M; Iwasaki H
Pathol Int; 2007 Jun; 57(6):351-7. PubMed ID: 17539966
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional aspects of complement activation by mannose-binding protein.
Wallis R
Immunobiology; 2002 Sep; 205(4-5):433-45. PubMed ID: 12396005
[TBL] [Abstract][Full Text] [Related]
33. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
[TBL] [Abstract][Full Text] [Related]
34. Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4.
Duncan RC; Bergström F; Coetzer TH; Blom AM; Wijeyewickrema LC; Pike RN
Mol Immunol; 2012 Jan; 49(4):593-600. PubMed ID: 22071314
[TBL] [Abstract][Full Text] [Related]
35. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity.
Sorensen GL; Petersen I; Thiel S; Fenger M; Christensen K; Kyvik KO; Sørensen TI; Holmskov U; Jensenius JC
Genet Epidemiol; 2007 Jan; 31(1):31-41. PubMed ID: 17096357
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants of the substrate specificity of the complement-initiating protease, C1r.
Wijeyewickrema LC; Yongqing T; Tran TP; Thompson PE; Viljoen JE; Coetzer TH; Duncan RC; Kass I; Buckle AM; Pike RN
J Biol Chem; 2013 May; 288(22):15571-80. PubMed ID: 23589288
[TBL] [Abstract][Full Text] [Related]
37. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2).
Zehnder A; Fisch U; Hirt A; Niggli FK; Simon A; Ozsahin H; Schlapbach LJ; Ammann RA
Pediatr Blood Cancer; 2009 Jul; 53(1):53-7. PubMed ID: 19343776
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into the initiating complex of the lectin pathway of complement activation.
Kjaer TR; Le le TM; Pedersen JS; Sander B; Golas MM; Jensenius JC; Andersen GR; Thiel S
Structure; 2015 Feb; 23(2):342-51. PubMed ID: 25579818
[TBL] [Abstract][Full Text] [Related]
39. A novel mannose-binding lectin-associated serine protease 1/3 gene variant.
Weiss G; Madsen HO; Garred P
Scand J Immunol; 2007 May; 65(5):430-4. PubMed ID: 17444953
[TBL] [Abstract][Full Text] [Related]
40. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation.
Matsushita M; Fujita T
Immunobiology; 1995 Nov; 194(4-5):443-48. PubMed ID: 8749236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
